gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

One year follow-up of the bifocal Morcher 43s intraocular lens

Meeting Abstract

  • corresponding author A.F. Scheuerle - Ruprecht-Karls-Universität Heidelberg, Universitäts-Augenklinik, Heidelberg
  • A.J. Reuland - Ruprecht-Karls-Universität Heidelberg, Universitäts-Augenklinik, Heidelberg
  • B.B. Entz - Ruprecht-Karls-Universität Heidelberg, Universitäts-Augenklinik, Heidelberg
  • F.E. Kruse - Friedrich-Alexander-Universität Erlangen-Nürnberg, Augenklinik mit Poliklinik, Erlangen
  • G.U. Auffarth - Ruprecht-Karls-Universität Heidelberg, Universitäts-Augenklinik, Heidelberg

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogP 069

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dog2004/04dog560.shtml

Published: September 22, 2004

© 2004 Scheuerle et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Objective

To investigate if the new Morcher 43s posterior chamber lens (PCIOL) combines bifocal lens design with the potentially accommodative characteristics of a circular haptic design.

Methods

12 eyes of 10 patients (mean age 66.4±17 years) received the acrylic PCIOL Morcher 43s (Morcher GmbH Stuttgart, Germany). Follow-up exams were performed 4-6 weeks, 6-8 months and 12-14 months postoperatively. Besides best corrected visual acuity (BCVA) and distance corrected near vision (DCNV), contrast sensitivity and post capsular opacification (PCO) were examined.

Results

Implantation of the lens with a shooter was uneventful and postoperative centration was excellent. 6-8 months after surgery, the BCVA for far distance was 0.64±0.11 while the DCNV was 0.39±0. The average pupil size was 2.8mm. The mean contrast sensitivity was within the normal range, two patients were treated with YAG capsulotomy because of PCO. There was no correlation between capsular ovarlapping and the DCNV.

Conclusions

The new potentially accommodative Morcher 43s with a bifocal zone can be safely implanted through a small incision and was well tolerated by our small study group. Initially refractive outcome was slightly hyperopic (+ 0.38 Dpt) which led to a correction factor when using the holiday formula. Functional results were as anticipated because of a limited visual potential in several patients.